Treatment of Bacterial Conjunctivitis
Topical broad-spectrum antibiotics are recommended for bacterial conjunctivitis as they reduce symptom duration, improve clinical outcomes, and allow earlier return to school/work. 1
First-Line Treatment Options
- Fluoroquinolones (ciprofloxacin 0.3%, ofloxacin 0.3%, levofloxacin 1.5%) are FDA-approved for bacterial conjunctivitis and have been shown to be effective as single-drug therapy 2
- Fourth-generation fluoroquinolones (moxifloxacin, gatifloxacin) have better coverage of gram-positive pathogens than earlier generation fluoroquinolones, though they are not FDA-approved specifically for bacterial conjunctivitis 2
- Erythromycin ophthalmic ointment is effective and should be applied directly to the infected eye(s) up to six times daily, depending on the severity of the infection 3
Treatment Approach Based on Severity
- For mild bacterial conjunctivitis: A 5-7 day course of broad-spectrum topical antibiotic accelerates clinical and microbiological remission and reduces transmissibility 1
- For moderate to severe bacterial conjunctivitis: Obtain conjunctival cultures and Gram staining before initiating treatment, especially if gonococcal infection is suspected 1
- For central or severe keratitis: A loading dose (every 5-15 minutes) followed by frequent applications (every hour) is recommended 2
Special Considerations
- Gonococcal conjunctivitis requires systemic antibiotic therapy rather than topical treatment alone, with saline lavage to promote comfort and faster resolution 1
- Chlamydial conjunctivitis requires systemic antibiotic therapy, especially in infants who may have infection at other sites 1
- Ointments may be useful at bedtime in less severe cases and for adjunctive therapy, though they have limited corneal penetration 2
- Cycloplegic agents may be used to decrease synechiae formation and reduce pain from anterior segment inflammation 2
Administration Guidelines
- Apply approximately 1 cm of ointment directly to the infected eye(s) 3
- For drops, frequency depends on severity - from twice daily for mild cases to hourly for severe cases 2, 1
- Studies show bacteria are cleared in 7 days in self-limiting cases, but a 7-day course of antibiotics has been shown to eradicate bacteria within 5 days 2
Potential Pitfalls and Considerations
- Bacterial resistance is a growing concern, particularly with MRSA infections 1
- Poor adherence to frequent administration regimens can contribute to treatment failure 4
- Individual risk factors for fluoroquinolone resistance include recent fluoroquinolone use, hospitalization, age, and recent ocular surgery 2
- Return for follow-up if no improvement after 3-4 days of treatment 1
- Indiscriminate use of topical antibiotics should be avoided as viral conjunctivitis will not respond to antibacterial agents 2
Most Common Pathogens
- Haemophilus influenzae and Streptococcus pneumoniae are the most prevalent bacteria in pediatric bacterial conjunctivitis 5
- Staphylococcus aureus, Staphylococcus epidermidis, and Moraxella species are also common pathogens 4